Literature DB >> 33952696

Impaired inhibitory GABAergic synaptic transmission and transcription studied in single neurons by Patch-seq in Huntington's disease.

Foteini Paraskevopoulou1,2, Poorya Parvizi3, Gökçe Senger3, Nurcan Tuncbag3,4,5, Christian Rosenmund6,2, Ferah Yildirim7,8.   

Abstract

Transcriptional dysregulation in Huntington's disease (HD) causes functional deficits in striatal neurons. Here, we performed Patch-sequencing (Patch-seq) in an in vitro HD model to investigate the effects of mutant Huntingtin (Htt) on synaptic transmission and gene transcription in single striatal neurons. We found that expression of mutant Htt decreased the synaptic output of striatal neurons in a cell autonomous fashion and identified a number of genes whose dysregulation was correlated with physiological deficiencies in mutant Htt neurons. In support of a pivotal role for epigenetic mechanisms in HD pathophysiology, we found that inhibiting histone deacetylase 1/3 activities rectified several functional and morphological deficits and alleviated the aberrant transcriptional profiles in mutant Htt neurons. With this study, we demonstrate that Patch-seq technology can be applied both to better understand molecular mechanisms underlying a complex neurological disease at the single-cell level and to provide a platform for screening for therapeutics for the disease.

Entities:  

Keywords:  Huntington’s disease; Patch-seq; single-cell RNA sequencing; striatum; synaptic function

Mesh:

Substances:

Year:  2021        PMID: 33952696      PMCID: PMC8126788          DOI: 10.1073/pnas.2020293118

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  59 in total

1.  Quantal components of the end-plate potential.

Authors:  J DEL CASTILLO; B KATZ
Journal:  J Physiol       Date:  1954-06-28       Impact factor: 5.182

2.  Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity.

Authors:  H Diana Rosas; David H Salat; Stephanie Y Lee; Alexandra K Zaleta; Vasanth Pappu; Bruce Fischl; Doug Greve; Nathanael Hevelone; Steven M Hersch
Journal:  Brain       Date:  2008-03-12       Impact factor: 13.501

Review 3.  What have we learned from gene expression profiles in Huntington's disease?

Authors:  Tamara Seredenina; Ruth Luthi-Carter
Journal:  Neurobiol Dis       Date:  2011-07-12       Impact factor: 5.996

4.  Developmental alterations in Huntington's disease neural cells and pharmacological rescue in cells and mice.

Authors: 
Journal:  Nat Neurosci       Date:  2017-03-20       Impact factor: 24.884

5.  Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene.

Authors:  J H Cha; C M Kosinski; J A Kerner; S A Alsdorf; L Mangiarini; S W Davies; J B Penney; G P Bates; A B Young
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

6.  Cell Type-Specific Transcriptomics Reveals that Mutant Huntingtin Leads to Mitochondrial RNA Release and Neuronal Innate Immune Activation.

Authors:  Hyeseung Lee; Robert J Fenster; S Sebastian Pineda; Whitney S Gibbs; Shahin Mohammadi; Jose Davila-Velderrain; Francisco J Garcia; Martine Therrien; Hailey S Novis; Fan Gao; Hilary Wilkinson; Thomas Vogt; Manolis Kellis; Matthew J LaVoie; Myriam Heiman
Journal:  Neuron       Date:  2020-07-17       Impact factor: 17.173

7.  NMDA receptor function in mouse models of Huntington disease.

Authors:  C Cepeda; M A Ariano; C R Calvert; J Flores-Hernández; S H Chandler; B R Leavitt; M R Hayden; M S Levine
Journal:  J Neurosci Res       Date:  2001-11-15       Impact factor: 4.164

8.  Predicting the functional states of human iPSC-derived neurons with single-cell RNA-seq and electrophysiology.

Authors:  C Bardy; M van den Hurk; B Kakaradov; J A Erwin; B N Jaeger; R V Hernandez; T Eames; A A Paucar; M Gorris; C Marchand; R Jappelli; J Barron; A K Bryant; M Kellogg; R S Lasken; B P F Rutten; H W M Steinbusch; G W Yeo; F H Gage
Journal:  Mol Psychiatry       Date:  2016-10-04       Impact factor: 15.992

9.  Neuropathological classification of Huntington's disease.

Authors:  J P Vonsattel; R H Myers; T J Stevens; R J Ferrante; E D Bird; E P Richardson
Journal:  J Neuropathol Exp Neurol       Date:  1985-11       Impact factor: 3.685

10.  WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs.

Authors:  Yuxing Liao; Jing Wang; Eric J Jaehnig; Zhiao Shi; Bing Zhang
Journal:  Nucleic Acids Res       Date:  2019-07-02       Impact factor: 16.971

View more
  2 in total

Review 1.  Molecular Pathophysiological Mechanisms in Huntington's Disease.

Authors:  Anamaria Jurcau
Journal:  Biomedicines       Date:  2022-06-17

2.  Impaired inhibitory GABAergic synaptic transmission and transcription studied in single neurons by Patch-seq in Huntington's disease.

Authors:  Foteini Paraskevopoulou; Poorya Parvizi; Gökçe Senger; Nurcan Tuncbag; Christian Rosenmund; Ferah Yildirim
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-11       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.